文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

双侧乳腺小叶原位癌中的胚系 CDH1 突变。

Germline CDH1 mutations in bilateral lobular carcinoma in situ.

机构信息

1] Research Oncology, Kings College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK [2] Medical and Molecular Genetics, Kings College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.

Research Oncology, Kings College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.

出版信息

Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24.


DOI:10.1038/bjc.2013.792
PMID:24366306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3929874/
Abstract

BACKGROUND: Invasive lobular breast cancer (ILC) and lobular carcinoma in situ (LCIS) are characterised by loss of E-cadherin expression. However germline CDH1 mutations are rare in cases of ILC with no family history of hereditary diffuse gastric cancer (HDGC) and have not been described in women with LCIS. METHODS: We screened the CDH1 gene in 50 cases of bilateral LCIS/ILC using Sanger sequencing and MLPA. RESULTS: Sanger sequencing revealed four pathogenic germline mutations, including a novel splicing mutation (c.48+1G>A). The remaining three (c.1465insC, c.1942G>T, c.2398delC) have been previously described. All four cases had bilateral LCIS +/- ILC and no family history of gastric cancer. CONCLUSION: CDH1 germline mutations have not been previously described in women with LCIS. We have shown that germline CDH1 mutations are associated with early onset of bilateral LCIS with or without ILC in women without a family history of gastric cancer. CDH1 mutation screening should be considered in women with early onset of bilateral LCIS/ILC with no family history of HDGC.

摘要

背景:浸润性小叶乳腺癌(ILC)和小叶原位癌(LCIS)的特征是 E-钙黏蛋白表达缺失。然而,家族性弥漫性胃癌(HDGC)病史阴性的 ILC 病例中种系 CDH1 突变罕见,并且在 LCIS 女性中尚未描述。

方法:我们使用 Sanger 测序和 MLPA 对 50 例双侧 LCIS/ILC 病例的 CDH1 基因进行了筛选。

结果:Sanger 测序显示了四个致病性种系突变,包括一个新的剪接突变(c.48+1G>A)。其余三个(c.1465insC、c.1942G>T、c.2398delC)以前已经描述过。这四个病例均有双侧 LCIS +/- ILC,且无胃癌家族史。

结论:以前未在 LCIS 女性中描述过 CDH1 种系突变。我们已经表明,种系 CDH1 突变与无胃癌家族史的女性双侧 LCIS 伴或不伴 ILC 的早发有关。对于无 HDGC 家族史的双侧 LCIS/ILC 早发的女性,应考虑进行 CDH1 突变筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/3929874/2429ba13def2/bjc2013792f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/3929874/2429ba13def2/bjc2013792f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a79/3929874/2429ba13def2/bjc2013792f1.jpg

相似文献

[1]
Germline CDH1 mutations in bilateral lobular carcinoma in situ.

Br J Cancer. 2013-12-24

[2]
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.

Mol Oncol. 2016-2

[3]
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

Gastroenterology. 2015-6-11

[4]
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.

Br J Cancer. 2000-2

[5]
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.

Mod Pathol. 2020-6

[6]
Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.

J Pathol. 2009-6

[7]
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.

Breast Cancer Res. 2017-1-17

[8]
Cadherin-catenin complex dissociation in lobular neoplasia of the breast.

Breast Cancer Res Treat. 2011-11-13

[9]
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.

J Med Genet. 2010-10-4

[10]
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.

Breast Cancer Res Treat. 2008-2

引用本文的文献

[1]
Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer.

J Cancer Res Clin Oncol. 2025-5-14

[2]
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.

NPJ Breast Cancer. 2025-1-24

[3]
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.

JAMA Netw Open. 2024-4-1

[4]
Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.

Cancer Treat Res. 2023

[5]
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

NPJ Breast Cancer. 2023-9-27

[6]
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?

Cancers (Basel). 2023-9-2

[7]
What Is Known about Breast Cancer in Young Women?

Cancers (Basel). 2023-3-22

[8]
Hereditary Diffuse Gastric Cancer: A 2022 Update.

J Pers Med. 2022-12-8

[9]
A Novel Variant Identified in a Chinese Family with Blepharocheilodontic Syndrome.

Diagnostics (Basel). 2022-11-24

[10]
Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.

J Surg Oncol. 2022-12

本文引用的文献

[1]
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.

J Med Genet. 2013-5-25

[2]
Comprehensive molecular characterization of human colon and rectal cancer.

Nature. 2012-7-18

[3]
Screening breast MR imaging in women with a history of lobular carcinoma in situ.

Radiology. 2011-9-7

[4]
Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.

Cancer. 2011-1-26

[5]
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.

J Med Genet. 2010-10-4

[6]
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

J Med Genet. 2010-7

[7]
Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.

J Pathol. 2008-11

[8]
Germline E-cadherin mutations in familial lobular breast cancer.

J Med Genet. 2007-11

[9]
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

JAMA. 2007-6-6

[10]
Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.

Ann Surg Oncol. 2007-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索